Veracyte Ownership | Who Owns Veracyte?
Veracyte Ownership Summary
Veracyte is owned by 4.62% institutional investors, 0.49% insiders, and 94.90% retail investors. Vanguard group is the largest institutional shareholder, holding 10.66% of VCYT shares. Vanguard Explorer Inv is the top mutual fund, with 3.40% of its assets in Veracyte shares.
VCYT Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Veracyte | 4.62% | 0.49% | 94.90% |
Sector | Healthcare Stocks | 279.18% | 10.62% | -189.80% |
Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Vanguard group | 8.21M | 10.66% | $325.18M |
Blackrock | 7.79M | 10.42% | $168.88M |
Blackrock funding, inc. /de | 7.53M | 9.77% | $298.00M |
Artisan partners limited partnership | 6.60M | 8.57% | $261.33M |
Ark investment management | 4.20M | 5.46% | $166.48M |
Wellington management group llp | 4.08M | 5.30% | $161.75M |
Arrowmark colorado | 3.08M | 4.00% | $121.97M |
State street | 2.91M | 3.89% | $63.03M |
Dimensional fund advisors lp | 2.88M | 3.74% | $114.16M |
Nikko asset management americas | 2.49M | 3.24% | $98.66M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Silverarc capital management | 503.28K | 4.36% | $19.93M |
Perkins capital management | 90.20K | 3.17% | $3.57M |
Next century growth investors | 577.68K | 1.71% | $22.88M |
Arrowmark colorado | 3.08M | 1.64% | $121.97M |
Oberweis asset management inc/ | 748.72K | 1.40% | $29.65M |
Ark investment management | 4.20M | 1.39% | $166.48M |
Efg asset management (north america) | 206.23K | 1.11% | $8.16M |
Granite investment partners | 649.02K | 1.11% | $25.70M |
Nikko asset management americas | 2.49M | 1.07% | $98.66M |
Casdin capital | 276.31K | 0.67% | $8.19M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Fmr | 2.08M | 0.00% | 2.02M |
Artisan partners limited partnership | 6.60M | 0.39% | 1.58M |
Marshall wace, llp | 956.58K | 0.05% | 846.49K |
Blackrock | 7.79M | 0.00% | 581.69K |
Point72 asset management | 523.16K | 0.05% | 523.16K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
State street | 2.91M | 0.00% | -1.42M |
William blair investment management | - | - | -811.79K |
Champlain investment partners | - | - | -800.36K |
Ark investment management | 4.20M | 1.39% | -716.79K |
Fiera capital | - | - | -625.54K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Loomis sayles & co l p | 409.70K | 0.02% | 409.70K | $16.22M |
Norges bank | 225.60K | 0.00% | 225.60K | $8.93M |
Raymond james financial | 41.06K | 0.00% | 41.06K | $1.63M |
D.a. davidson | 23.35K | 0.01% | 23.35K | $924.82K |
Y-intercept (hong kong) | 21.36K | 0.06% | 21.36K | $845.90K |
Sold Out
Holder | Change |
---|---|
Newedge advisors | -2.00 |
Kohmann bosshard financial services | -6.00 |
Opal wealth advisors | -13.00 |
First command advisory services | -20.00 |
Covestor | -22.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 9 | -97.20% | 3,530,599 | -95.70% | 4 | 0.04% | 5 | -96.84% | 3 | -97.41% |
Dec 31, 2024 | 301 | 2.73% | 77,106,580 | -5.52% | 100 | 0.89% | 145 | -9.94% | 109 | 22.47% |
Sep 30, 2024 | 292 | 22.18% | 81,612,672 | -0.60% | 105 | 0.88% | 162 | 38.46% | 88 | 7.32% |
Jun 30, 2024 | 239 | -2.05% | 82,106,462 | 0.48% | 109 | 0.92% | 117 | -21.48% | 82 | 24.24% |
Mar 31, 2024 | 244 | -3.17% | 81,711,223 | 5.83% | 109 | 0.98% | 149 | 29.57% | 66 | -37.14% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Explorer Inv | 2.66M | 3.40% | -37.11K |
ARK Disruptive Innovation Full Composite | 2.48M | 3.18% | -205.91K |
Vanguard Total Stock Mkt Idx Inv | 2.48M | 3.17% | 41.22K |
Vanguard US Total Market Shares ETF | 2.46M | 3.16% | 2.69K |
iShares Russell 2000 ETF | 2.00M | 2.55% | 978.00 |
Vanguard Small Cap Index | 1.95M | 2.48% | 9.19K |
ARK Innovation ETF | 1.90M | 2.42% | -2.84K |
Fidelity Select Medical Tech and Devcs | 1.89M | 2.41% | 446.33K |
Nikko AM ARK Disruptive Innovation A USD | 1.46M | 1.87% | -202.63K |
Fidelity Select Health Care | 1.28M | 1.64% | 435.00K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jun 04, 2025 | Leite John | Chief Commercial Officer-CLIA | Sell | $76.41K |
Mar 07, 2025 | Leite John | Chief Commercial Officer-CLIA | Sell | $74.48K |
Mar 07, 2025 | Leite John | Chief Commercial Officer-CLIA | Sell | $160.15K |
Mar 04, 2025 | Febbo Phillip G. | Chief Scientific & Med Officer | Sell | $121.21K |
Mar 04, 2025 | Febbo Phillip G. | Chief Scientific & Med Officer | Sell | $146.81K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | - | 1 |
2025 Q1 | - | 12 |
2024 Q4 | - | 13 |
2024 Q3 | - | 21 |
2024 Q2 | - | 5 |
VCYT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools